small win: TGA stopped being a problem at week 55
compounding. That is the whole post, but I will justify it. Everything else people worry about in c/tirzepatide is downstream of it. Titration speed, reflux, the endless dose arguments — most of it resolves if you sort compounding out first, and almost nobody does. I say this having got it wrong for 20 months. My…
Strongly agree. AU and NZ differ.
PBS/TGA claims need the notice or schedule entry
Small correction: the trial was 18 weeks, not 20. Does not change your point but people will quote it.
That is net peptide content, not purity. Different number, different meaning.
no naming compounders operating against current rules
AU and NZ are different systems, say which
The confident tone is doing a lot of work that the evidence is not.